Can Tetrahydrocannabinol (THC) capsules cause Cannabinoid Hyperemesis Syndrome (CHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

THC Capsules Can Cause Cannabinoid Hyperemesis Syndrome

Yes, THC capsules can definitely cause Cannabinoid Hyperemesis Syndrome (CHS), as any form of THC consumption, including oral formulations like capsules, can trigger this condition in regular users. 1

Understanding Cannabinoid Hyperemesis Syndrome

Cannabinoid Hyperemesis Syndrome is a disorder of gut-brain interaction characterized by:

  • Cyclic episodes of nausea and vomiting
  • Abdominal pain
  • Relief of symptoms with hot baths or showers (reported in 71% of cases)
  • Resolution of symptoms after cannabis cessation

Diagnostic Criteria for CHS 1

  1. Clinical features:

    • Stereotypical episodic vomiting occurring 3 or more times annually
  2. Cannabis use patterns:

    • Duration of cannabis use exceeding 1 year before symptom onset
    • Frequency of use more than 4 times per week on average
  3. Cannabis cessation:

    • Resolution of symptoms after abstinence from cannabis for at least 6 months or a period equal to the duration of 3 typical vomiting cycles

Why THC Capsules Can Cause CHS

The development of CHS is related to the THC content and chronic use rather than the method of consumption. While most research has focused on smoked cannabis, the syndrome can occur with any form of THC administration, including oral formulations like capsules 2. Key points:

  • THC is the primary psychoactive component responsible for CHS
  • Oral THC products (including capsules) contain the same active compound that triggers CHS
  • The syndrome is associated with long-term, regular use regardless of administration route

Risk Factors for Developing CHS

The likelihood of developing CHS increases with:

  • Daily or near-daily cannabis use 2
  • Duration of use exceeding 1-2 years 1
  • Higher THC content in cannabis products 2
  • Regular consumption exceeding 4 times per week 1

Clinical Course and Complications

CHS can lead to serious complications:

  • Dehydration from persistent vomiting
  • Electrolyte imbalances
  • Weight loss
  • Potential fatal outcomes in rare cases 3
  • Significant healthcare resource utilization through emergency department visits and hospitalizations 2

Management of CHS

The cornerstone of CHS management is cannabis cessation 1, 2. For acute symptoms, treatments may include:

  • Topical capsaicin application
  • Benzodiazepines
  • Haloperidol
  • Promethazine
  • Olanzapine

Important caveat: Opioids should be avoided as they can worsen nausea and carry addiction risk 1.

Common Pitfalls in CHS Management

  1. Misdiagnosis: CHS is often confused with cyclic vomiting syndrome or other gastrointestinal disorders 4

  2. Patient skepticism: Many patients are reluctant to accept cannabis as the cause of their symptoms 2

  3. Continued cannabis use: Patients may continue using cannabis despite symptoms due to perceived benefits or dependence 2

  4. Delayed diagnosis: The condition often leads to extensive medical investigations and healthcare costs before proper diagnosis 5

Conclusion

If you're experiencing recurrent nausea, vomiting, and abdominal pain while using THC capsules regularly, CHS should be strongly considered as a potential diagnosis. The definitive treatment is complete cessation of all cannabis products, including THC capsules.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.

Journal of forensic sciences, 2019

Research

[Cannabinoid hyperemesis syndrome: about 6 cases].

La Revue de medecine interne, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.